Neutralization of MERS coronavirus through a scalable nanoparticle vaccine

MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competent genetic...

Celý popis

Podrobná bibliografia

Vydané v:	npj vaccines Ročník 6; číslo 1; s. 107 - 9
Hlavní autori:	Mohsen, Mona O., Rothen, Dominik, Balke, Ina, Martina, Byron, Zeltina, Vilija, Inchakalody, Varghese, Gharailoo, Zahra, Nasrallah, Gheyath, Dermime, Said, Tars, Kaspars, Vogel, Monique, Zeltins, Andris, Bachmann, Martin F.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 24.08.2021 Nature Publishing Group Nature Portfolio
Predmet:	631/250 631/250/590/2294 Biomedical and Life Sciences Biomedicine E coli Hepatitis Infectious Diseases Medical Microbiology Middle East respiratory syndrome Neutralization Public Health Toxins Vaccine Vaccines Virology
ISSN:	2059-0105, 2059-0105
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!